Eli Lilly’s Next-Generation Weight-Loss Shot Clears Another Hurdle
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Eli Lilly & Co.’s highly anticipated next-generation weight-loss shot didn’t increase overall heart risk in a new study, the company said, helping dispel lingering concerns over its potential as it nears regulatory review.
This development is significant as it comes ahead of the product's regulatory review, potentially paving the way for its market introduction.
Eli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Eli Lilly & Co.’s highly anticipated next-generation weight-loss shot didn’t increase overall heart risk in a new study, the company said, helping dispel lingering concerns over its potential as it nears regulatory review.”
Bloomberg — Eli Lilly’s Next-Generation Weight-Loss Shot Clears Another Hurdle